ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)
systemic lupus erythematosus, lupus nephritis, car-t therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 801037
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.